{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:09:51Z","timestamp":1790388591425,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["386936527"],"award-info":[{"award-number":["386936527"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0140"],"award-info":[{"award-number":["P1-0140"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008131","name":"Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ymthe.2023.08.019","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T02:00:45Z","timestamp":1693274445000},"page":"2962-2974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy"],"prefix":"10.1016","volume":"31","author":[{"given":"Claudia","family":"Yaghootfam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"Gieselmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-3875","authenticated-orcid":false,"given":"Ulrich","family":"Matzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.08.019_bib1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymgme.2011.12.012","article-title":"Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction","volume":"105","author":"Coutinho","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2023.08.019_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/0929867328666210526144654","article-title":"Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency","volume":"29","author":"Marchetti","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.08.019_bib5","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/hmg\/ddr175","article-title":"Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy","volume":"20","author":"Stroobants","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.08.019_bib6","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"Matthes","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.08.019_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1\/2 clinical trial","volume":"131","author":"\u00cd Dali","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2023.08.019_bib8","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Metachromatic Leukodystrophy","author":"Gieselmann","year":"2019"},{"key":"10.1016\/j.ymthe.2023.08.019_bib9","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood-2016-03-708479","article-title":"Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: the Dutch experience","volume":"127","author":"van Rappard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2023.08.019_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","article-title":"Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients","volume":"73","author":"Groeschel","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymthe.2023.08.019_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2023.08.019_bib12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11011-021-00893-3","article-title":"Drug delivery for neuronopathic lysosomal storage diseases: evolving roles of the blood brain barrier and cerebrospinal fluid","volume":"37","author":"Sato","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymthe.2023.08.019_bib13","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1523\/JNEUROSCI.4785-13.2014","article-title":"Comparison of five peptide vectors for improved brain delivery of the lysosomal enzyme arylsulfatase A","volume":"34","author":"B\u00f6ckenhoff","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2023.08.019_bib14","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/hmg\/ddz020","article-title":"Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy","volume":"28","author":"Simonis","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.08.019_bib15","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0024-3205(94)00659-8","article-title":"Increased activities of cathepsin B and other lysosomal hydrolases in fibroblasts and bone tissue cultured in the presence of cysteine proteinases inhibitors","volume":"55","author":"Montenez","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2023.08.019_bib16","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/bi9714924","article-title":"Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis","volume":"37","author":"Lukatela","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymthe.2023.08.019_bib17","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tips.2017.06.003","article-title":"The Future of Cysteine Cathepsins in Disease Management","volume":"38","author":"Kramer","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2023.08.019_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1742-4658.2005.04553.x","article-title":"Missense mutations as a cause of metachromatic leukodystrophy. Degradation of arylsulfatase A in the endoplasmic reticulum","volume":"272","author":"Poeppel","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2023.08.019_bib19","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/hmg\/ddaa277","article-title":"Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy","volume":"29","author":"Kaminski","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.08.019_bib20","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1074\/jbc.M111993200","article-title":"Defective oligomerization of arylsulfatase a as a cause of its instability in lysosomes and metachromatic leukodystrophy","volume":"277","author":"von B\u00fclow","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/tra.12284","article-title":"Lrp1\/LDL Receptor Play Critical Roles in Mannose 6-Phosphate-Independent Lysosomal Enzyme Targeting","volume":"16","author":"Markmann","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.ymthe.2023.08.019_bib22","doi-asserted-by":"crossref","first-page":"23342","DOI":"10.1016\/S0021-9258(18)50097-1","article-title":"Lysosomal enzyme phosphorylation. I. Protein recognition determinants in both lobes of procathepsin D mediate its interaction with UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase","volume":"267","author":"Baranski","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib23","doi-asserted-by":"crossref","first-page":"32653","DOI":"10.1074\/jbc.M304865200","article-title":"Recognition of arylsulfatase A and B by the UDP-N-acetylglucosamine:lysosomal enzyme N-acetylglucosamine-phosphotransferase","volume":"278","author":"Yaghootfam","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib24","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.08.019_bib25","article-title":"Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice","volume":"21","author":"Gustavsson","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2023.08.019_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2144\/97234bm01","article-title":"Modification of a PCR-based site-directed mutagenesis method","volume":"23","author":"Fisher","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymthe.2023.08.019_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0009-8981(59)90119-6","article-title":"The assay of arylsulphatases A and B in human urine","volume":"4","author":"Baum","year":"1959","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymthe.2023.08.019_bib28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.gt.3301150","article-title":"Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cells","volume":"7","author":"Matzner","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2023.08.019_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1046-2023(03)00212-3","article-title":"Production and activation of recombinant papain-like cysteine proteases","volume":"32","author":"Br\u00f6mme","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.ymthe.2023.08.019_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0003-2697(92)90061-B","article-title":"In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis","volume":"203","author":"Rosenfeld","year":"1992","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/abio.1995.1010","article-title":"Internal sequences from proteins digested in polyacrylamide gels","volume":"224","author":"Jen\u00f6","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2023.08.019_bib32","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2023.08.019_bib33","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1073\/pnas.93.25.14821","article-title":"Phenotype of arylsulfatase A-deficient mice: relationship to human metachromatic leukodystrophy","volume":"93","author":"Hess","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.08.019_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00109-008-0309-3","article-title":"Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease","volume":"86","author":"Matzner","year":"2008","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.ymthe.2023.08.019_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/hmg\/ddi126","article-title":"Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy","volume":"14","author":"Matzner","year":"2005","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:08:36Z","timestamp":1761502116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1525001623004495"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.08.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}